349 related articles for article (PubMed ID: 16309971)
1. Lysophosphatidylcholine-induced elevation of asymmetric dimethylarginine level by the NADPH oxidase pathway in endothelial cells.
Jia SJ; Jiang DJ; Hu CP; Zhang XH; Deng HW; Li YJ
Vascul Pharmacol; 2006 Mar; 44(3):143-8. PubMed ID: 16309971
[TBL] [Abstract][Full Text] [Related]
2. Probucol decreases asymmetrical dimethylarginine level by alternation of protein arginine methyltransferase I and dimethylarginine dimethylaminohydrolase activity.
Jiang JL; Zhang XH; Li NS; Rang WQ; Feng-Ye ; Hu CP; Li YJ; Deng HW
Cardiovasc Drugs Ther; 2006 Aug; 20(4):281-94. PubMed ID: 16897158
[TBL] [Abstract][Full Text] [Related]
3. Gene transfer of dimethylarginine dimethylaminohydrolase-2 improves the impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells induced by lysophosphatidylcholine.
Feng M; Liu L; Guo Z; Xiong Y
Eur J Pharmacol; 2008 Apr; 584(1):49-56. PubMed ID: 18342305
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of neferine on endothelial cell nitric oxide production induced by lysophosphatidylcholine: the role of the DDAH-ADMA pathway.
Peng ZY; Zhang SD; Liu S; He BM
Can J Physiol Pharmacol; 2011 Apr; 89(4):289-94. PubMed ID: 21526974
[TBL] [Abstract][Full Text] [Related]
5. The ADMA/DDAH/NO pathway in human vein endothelial cells exposed to arsenite.
Osorio-Yáñez C; Chin-Chan M; Sánchez-Peña LC; Atzatzi-Aguilar OG; Olivares-Reyes JA; Segovia J; Del Razo LM
Toxicol In Vitro; 2017 Aug; 42():281-286. PubMed ID: 28502835
[TBL] [Abstract][Full Text] [Related]
6. PRMT-1 and DDAHs-induced ADMA upregulation is involved in ROS- and RAS-mediated diabetic retinopathy.
Chen Y; Xu X; Sheng M; Zhang X; Gu Q; Zheng Z
Exp Eye Res; 2009 Dec; 89(6):1028-34. PubMed ID: 19748504
[TBL] [Abstract][Full Text] [Related]
7. Asymmetric dimethylarginine damages connexin43-mediated endothelial gap junction intercellular communication.
Jia SJ; Zhou Z; Zhang BK; Hu ZW; Deng HW; Li YJ
Biochem Cell Biol; 2009 Dec; 87(6):867-74. PubMed ID: 19935872
[TBL] [Abstract][Full Text] [Related]
8. Taurine protects against low-density lipoprotein-induced endothelial dysfunction by the DDAH/ADMA pathway.
Tan B; Jiang DJ; Huang H; Jia SJ; Jiang JL; Hu CP; Li YJ
Vascul Pharmacol; 2007 May; 46(5):338-45. PubMed ID: 17293168
[TBL] [Abstract][Full Text] [Related]
9. Involvement of the endothelial DDAH/ADMA pathway in nitroglycerin tolerance: the role of ALDH-2.
Zhang GG; Shi RZ; Jiang DJ; Chen YR; Jia-Chen ; Tang ZY; Bai YP; Xiao HB; Li YJ
Life Sci; 2008 Mar; 82(13-14):699-707. PubMed ID: 18289604
[TBL] [Abstract][Full Text] [Related]
10. Icariin regulates PRMT/ADMA/DDAH pathway to improve endothelial function.
Xiao HB; Liu ZK; Lu XY; Deng CN; Luo ZF
Pharmacol Rep; 2015 Dec; 67(6):1147-54. PubMed ID: 26481534
[TBL] [Abstract][Full Text] [Related]
11. Regulation by DDAH/ADMA pathway of lipopolysaccharide-induced tissue factor expression in endothelial cells.
Xin HY; Jiang DJ; Jia SJ; Song K; Wang GP; Li YJ; Chen FP
Thromb Haemost; 2007 May; 97(5):830-8. PubMed ID: 17479195
[TBL] [Abstract][Full Text] [Related]
12. [Neferine protects endothelial cells against damages induced by LPC and relationship with asymmetric dimethylarginine].
Zhang SD; Peng ZY; Liu S; Pei ZF; Chen F; Yang L
Zhongguo Zhong Yao Za Zhi; 2008 Nov; 33(21):2526-9. PubMed ID: 19149265
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of resveratrol derivative BTM-0512 on high glucose-induced cell senescence involves dimethylaminohydrolase/asymmetric dimethylarginine pathway.
Yuan Q; Peng J; Liu SY; Wang CJ; Xiang DX; Xiong XM; Hu CP; Li YJ
Clin Exp Pharmacol Physiol; 2010 May; 37(5-6):630-5. PubMed ID: 20132235
[TBL] [Abstract][Full Text] [Related]
14. The effect of nebivolol on asymmetric dimethylarginine system in spontaneously hypertension rats.
Wang Y; Zhang M; Liu Y; Liu Y; Chen M
Vascul Pharmacol; 2011; 54(1-2):36-43. PubMed ID: 21167314
[TBL] [Abstract][Full Text] [Related]
15. Estradiol, acting through estrogen receptor alpha, restores dimethylarginine dimethylaminohydrolase activity and nitric oxide production in oxLDL-treated human arterial endothelial cells.
Novella S; Laguna-Fernández A; Lázaro-Franco M; Sobrino A; Bueno-Betí C; Tarín JJ; Monsalve E; Sanchís J; Hermenegildo C
Mol Cell Endocrinol; 2013 Jan; 365(1):11-6. PubMed ID: 22982060
[TBL] [Abstract][Full Text] [Related]
16. Lysophosphatidylcholine-induced modulation of Ca(2+)-activated K(+)channels contributes to ROS-dependent proliferation of cultured human endothelial cells.
Wolfram Kuhlmann CR; Wiebke Lüdders D; Schaefer CA; Kerstin Most A; Backenköhler U; Neumann T; Tillmanns H; Erdogan A
J Mol Cell Cardiol; 2004 May; 36(5):675-82. PubMed ID: 15135662
[TBL] [Abstract][Full Text] [Related]
17. Age-related changes in ADMA-DDAH-NO pathway in rat liver subjected to partial ischemia followed by global reperfusion.
Trocha M; Merwid-Ląd A; Chlebda-Sieragowska E; Szuba A; Pieśniewska M; Fereniec-Gołębiewska L; Kwiatkowska J; Szeląg A; Sozański T
Exp Gerontol; 2014 Feb; 50():45-51. PubMed ID: 24269305
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of kaempferol against endothelial damage by an improvement in nitric oxide production and a decrease in asymmetric dimethylarginine level.
Xiao HB; Jun-Fang ; Lu XY; Chen XJ; Chao-Tan ; Sun ZL
Eur J Pharmacol; 2009 Aug; 616(1-3):213-22. PubMed ID: 19549512
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanism for elevation of asymmetric dimethylarginine and its role for hypertension in chronic kidney disease.
Matsuguma K; Ueda S; Yamagishi S; Matsumoto Y; Kaneyuki U; Shibata R; Fujimura T; Matsuoka H; Kimoto M; Kato S; Imaizumi T; Okuda S
J Am Soc Nephrol; 2006 Aug; 17(8):2176-83. PubMed ID: 16807406
[TBL] [Abstract][Full Text] [Related]
20. Variance of DDAH/PRMT/ADMA pathway in atrial fibrillation dogs.
Liu H; Qu X; Liang Z; Chen W; Xia W; Song Y
Biochem Biophys Res Commun; 2008 Dec; 377(3):884-8. PubMed ID: 18951871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]